These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2451306

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C, Lämmle B, Duckert F.
    Thromb Haemost; 1985 Apr 22; 53(2):242-4. PubMed ID: 2410997
    [Abstract] [Full Text] [Related]

  • 3. Behaviour of the contact phase of blood coagulation in the adult respiratory distress syndrome (ARDS).
    Velasco F, Torres A, Guerrero A, Andres P, Guerrero R, Aljama P, Alvarez F.
    Thromb Haemost; 1986 Jun 30; 55(3):357-60. PubMed ID: 2428125
    [Abstract] [Full Text] [Related]

  • 4. Western blot analyses of prekallikrein and its activation products in human plasma.
    Veloso D, Colman RW.
    Thromb Haemost; 1991 Apr 08; 65(4):382-8. PubMed ID: 1711719
    [Abstract] [Full Text] [Related]

  • 5. The contact phase of blood coagulation in diabetes mellitus and in patients with vasculopathy.
    Christe M, Gattlen P, Fritschi J, Lämmle B, Berger W, Marbet GA, Duckert F.
    Thromb Haemost; 1984 Dec 29; 52(3):221-3. PubMed ID: 6085193
    [Abstract] [Full Text] [Related]

  • 6. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
    Lämmle B, Tran TH, Ritz R, Duckert F.
    Am J Clin Pathol; 1984 Oct 29; 82(4):396-404. PubMed ID: 6206713
    [Abstract] [Full Text] [Related]

  • 7. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
    Carvalho AC, DeMarinis S, Scott CF, Silver LD, Schmaier AH, Colman RW.
    J Lab Clin Med; 1988 Aug 29; 112(2):270-7. PubMed ID: 3397629
    [Abstract] [Full Text] [Related]

  • 8. Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: implications for septic shock.
    Hack CE, Wagstaff J, Strack van Schijndel RJ, Eerenberg AJ, Pinedo HM, Thijs LG, Nuijens JH.
    Thromb Haemost; 1991 May 06; 65(5):497-503. PubMed ID: 1871710
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of C1-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates.
    Tassani P, Kunkel R, Richter JA, Oechsler H, Lorenz HP, Braun SL, Eising GP, Haas F, Paek SU, Bauernschmitt R, Jochum M, Lange R.
    J Cardiothorac Vasc Anesth; 2001 Aug 06; 15(4):469-73. PubMed ID: 11505352
    [Abstract] [Full Text] [Related]

  • 11. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.
    Jansen PM, Eisele B, de Jong IW, Chang A, Delvos U, Taylor FB, Hack CE.
    J Immunol; 1998 Jan 01; 160(1):475-84. PubMed ID: 9552006
    [Abstract] [Full Text] [Related]

  • 12. Plasma kallikrein activation and inhibition during typhoid fever.
    Colman RW, Edelman R, Scott CF, Gilman RH.
    J Clin Invest; 1978 Feb 01; 61(2):287-96. PubMed ID: 74379
    [Abstract] [Full Text] [Related]

  • 13. Kallikrein and prekallikrein levels in a large number of congenital clotting deficiencies and abnormalities.
    Patrassi GM, Martinelli S, Vianello C, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Feb 01; 109(4):644-54. PubMed ID: 6184289
    [Abstract] [Full Text] [Related]

  • 14. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor.
    Gluszko P, Undas A, Amenta S, Szczeklik A, Schmaier AH.
    J Lab Clin Med; 1994 Feb 01; 123(2):232-40. PubMed ID: 8301199
    [Abstract] [Full Text] [Related]

  • 15. Some haemostatic parameters in patients with deep and superficial venous thrombosis.
    Krupiński K, Bodzenta-Lukaszyk A, Lussa A, Bielawiec M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990 Feb 01; 117(1):173-8. PubMed ID: 1695173
    [Abstract] [Full Text] [Related]

  • 16. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
    Paydaş S, Balal M, Sertdemir Y, Seyrek N, Karayaylali I.
    Ren Fail; 2005 Feb 01; 27(4):409-13. PubMed ID: 16060128
    [Abstract] [Full Text] [Related]

  • 17. A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII.
    Dors DM, Nuijens JH, Huijbregts CC, Hack CE.
    Thromb Haemost; 1992 Jun 01; 67(6):644-8. PubMed ID: 1509403
    [Abstract] [Full Text] [Related]

  • 18. Level of plasma prekallikrein and its inhibitors in reactors and nonreactors during intravenous enhancement with contrast media.
    Aronen HJ, Kivisaari L, Torstila I, Paavonen T, Meri S, Karonen SL, Standertskjöld-Nordenstam CG.
    Acta Radiol; 1992 Jul 01; 33(4):374-8. PubMed ID: 1378750
    [Abstract] [Full Text] [Related]

  • 19. Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study.
    Roeise O, Bouma BN, Stadaas JO, Aasen AO.
    Circ Shock; 1988 Dec 01; 26(4):419-30. PubMed ID: 2463883
    [Abstract] [Full Text] [Related]

  • 20. Plasma kallikrein-kinin system in patients with uncomplicated sepsis and septic shock--comparison with cardiogenic shock.
    Martínez-Brotóns F, Oncins JR, Mestres J, Amargós V, Reynaldo C.
    Thromb Haemost; 1987 Aug 04; 58(2):709-13. PubMed ID: 3672421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.